We are live on ! Find out more
GILD icon

Gilead Sciences
GILD

1,439 hedge funds and large institutions have $120B invested in Gilead Sciences in 2014 Q4 according to their latest regulatory filings, with 216 funds opening new positions, 604 increasing their positions, 518 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more first-time investments, than exits

New positions opened: 216 | Existing positions closed: 90

17% more repeat investments, than reductions

Existing positions increased: 604 | Existing positions reduced: 518

8% more funds holding

Funds holding: 1,327 → 1,439 (+112)

13% less capital invested

Capital invested by funds: $139B → $120B (-$18.6B)

18% less funds holding in top 10

Funds holding in top 10: 240 → 196 (-44)

32% less call options, than puts

Call options by funds: $3.07B | Put options by funds: $4.55B

Holders
1,439
Holders Change
+112
Holders Change %
+8.44%
% of All Funds
38.36%
Holding in Top 10
196
Holding in Top 10 Change
-44
Holding in Top 10 Change %
-18.33%
% of All Funds
5.23%
New
216
Increased
604
Reduced
518
Closed
90
Calls
$3.07B
Puts
$4.55B
Net Calls
-$1.48B
Net Calls Change
-$53.3M

Top Buyers

Rank Fund Capital Flow
1
Temasek Holdings
Temasek Holdings
Singapore
+$811M
2
Bank of New York Mellon
Bank of New York Mellon
New York
+$531M
3
Goldman Sachs
Goldman Sachs
New York
+$325M
4
AQR Capital Management
AQR Capital Management
Connecticut
+$266M
5
State Street
State Street
Massachusetts
+$256M

Top Sellers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
-$2.53B
2
Capital World Investors
Capital World Investors
California
-$1.63B
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$756M
4
Invesco
Invesco
Georgia
-$619M
5
Ameriprise
Ameriprise
Minnesota
-$552M
Name Holding Trade Value Shares
Change 		Change in
Stake
FM
876
Family Management
New York
$1.85M +$2.03M +19,650 New
BKA
877
Brick & Kyle Associates
Pennsylvania
$1.85M +$2.03M +19,600 New
AW
878
ACG Wealth
Georgia
$1.84M -$753K -7,281 -27%
MSP
879
Madison Street Partners
Colorado
$1.84M +$2.02M +19,500 New
TAM
880
Tealwood Asset Management
Minnesota
$1.84M +$44K +425 +2%
MTIM
881
Marathon Trading Investment Management
Pennsylvania
$1.81M +$248K +2,400 +14%
AF
882
Aldebaran Financial
$1.78M +$101K +979 +5%
ST
883
Spinnaker Trust
Maine
$1.78M -$33.7K -326 -2%
PCM
884
Prelude Capital Management
New York
$1.77M -$662K -6,400 -25%
AGM
885
Alpine Global Management
New York
$1.77M +$1.94M +18,780 New
SAM
886
Silvercrest Asset Management
New York
$1.76M +$197K +1,900 +11%
BC
887
Birchview Capital
Vermont
$1.76M +$1.93M +18,670 New
OA
888
OFI Advisors
Pennsylvania
$1.76M +$325K +3,144 +20%
LWM
889
LBA Wealth Management
Florida
$1.75M -$207K -2,000 -10%
RC
890
Roundview Capital
New Jersey
$1.73M +$1.9M +18,384 New
DD
891
Dominick & Dominick
New York
$1.72M -$603K -5,835 -24%
ICAS
892
Investors Capital Advisory Services
Massachusetts
$1.71M -$241K -2,329 -11%
PIA
893
Peachtree Investment Advisors
Georgia
$1.71M +$1.87M +18,100 New
PAI
894
Pittenger & Anderson Inc
Nebraska
$1.7M +$1.74M +16,870 +1,442%
CK
895
Cohen Klingenstein
New York
$1.69M -$405K -3,920 -18%
ACM
896
Aviance Capital Management
Florida
$1.68M +$11.8K +114 +0.6%
AMM
897
American Money Management
California
$1.66M +$65.7K +635 +4%
FCMC
898
Founders Capital Management (Connecticut)
Connecticut
$1.66M +$299K +2,890 +20%
HIM
899
Hutchens Investment Management
New Hampshire
$1.65M +$1.81M +17,540 New
MFS
900
McNamara Financial Services
Massachusetts
$1.65M +$1.81M +17,540 New
34 35
36
37 38

GILD Hedge Fund Activity: Q4 2014 in Review

1,439 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q4 2014, worth a combined $120B — down 13% from $139B a quarter earlier.

Buyers outnumbered sellers: 216 funds opened new GILD positions and 90 closed out — a net gain of 126 holders — while 604 added to existing stakes and 518 trimmed.

The largest buyer was Temasek Holdings, adding an estimated $811M. The largest seller was Capital Research Global Investors, cutting an estimated $2.53B.

  • 1,439 institutional investors held Gilead Sciences (GILD) as of Q4 2014, up from 1,327 in Q3 2014.
  • Funds reported $120B of Gilead Sciences stock for Q4 2014, down 13% quarter-over-quarter.
  • 216 funds opened new Gilead Sciences positions in Q4 2014 and 90 closed out, a net change of +126 holders.
  • The largest Gilead Sciences buyer in Q4 2014 was Temasek Holdings, an estimated $811M added.
  • The largest Gilead Sciences seller in Q4 2014 was Capital Research Global Investors, an estimated $2.53B sold.

Based on aggregated 13F filings for Q4 2014.